PCR

ProAmpac Showcases Expanded Sustainable Packaging Solutions at Petfood Forum 2024

Retrieved on: 
Tuesday, April 23, 2024
Packaging, Retail, Consumer, Manufacturing, Pets, Other Manufacturing, Food, Beverage, PCR, Multimedia, Marketing, SOS, ProActive, Recycling, Booth, Carbon footprint

ProAmpac , a global leader in flexible packaging and material science, will showcase its latest sustainable packaging advancements at Petfood Forum 2024 from April 29-May 1 in Kansas City, Missouri.

Key Points: 
  • ProAmpac , a global leader in flexible packaging and material science, will showcase its latest sustainable packaging advancements at Petfood Forum 2024 from April 29-May 1 in Kansas City, Missouri.
  • View the full release here: https://www.businesswire.com/news/home/20240423266606/en/
    - PRO-EVO® Recyclable is a pre-qualified curbside recyclable multi-wall SOS bag.
  • ProAmpac's product development manager, Nicole Cocuzzi highlights the company's commitment: “Our recyclable film, fiber, and PCR-based packaging help pet brands achieve their sustainability goals without sacrificing performance or aesthetics.” ProAmpac also offers sustainable packaging education and collaboration through its ProActive Sustainability platform.
  • Visit ProAmpac at Booth 2002 to explore its latest sustainable packaging innovations at Petfood Forum 2024.

Hera Biotech Announces Positive Interim Results From Endometriosis Diagnostic Study

Retrieved on: 
Tuesday, April 23, 2024
General Health, Professional Services, Consumer, Technology, Artificial Intelligence, Genetics, Health Technology, Data Analytics, Clinical Trials, Women, Biotechnology, Health, University, Executive, Woman, Hera, Infertility, Endometriosis, Uterus, Female, PCR, DRS, Disease, Therapy, Patient, CSO, Diagnosis, Biomarker, AUC

Hera Biotech is pleased to report the interim results for its proof-of-concept multi-center clinical trial of the MetriDx™ endometriosis diagnostic test.

Key Points: 
  • Hera Biotech is pleased to report the interim results for its proof-of-concept multi-center clinical trial of the MetriDx™ endometriosis diagnostic test.
  • “This result suggests that Hera’s molecular diagnostic test has the potential to replace surgical diagnosis and greatly improve the woefully inadequate state of endometriosis diagnosis and treatment that exists today,” said Hera Biotech CEO Somer Baburek.
  • Hera is focused on a tissue based approach for diagnosing endometriosis, utilizing a pipelle to non-surgically obtain endometrial cells for analysis.
  • Based on these promising results, Hera intends to bring a rapid bulk PCR endometriosis diagnostic test to market in 2025.

The Market and Future Potential for Molecular Point-of-Care (mPOC) Report, 11th Edition, with Profiles of 30+ Key Industry Players - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 10, 2024
General Health, Infectious Diseases, Biometrics, Health, Medical Supplies, Cepheid variable, Clinic, Molecule, Forecasting, Point-of-care testing, PCR, BioMérieux, Patient, Microbiology, Market, POC, COVID-19, IVD, Growth, Row

The "Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition" report has been added to ResearchAndMarkets.com's offering.
  • Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests.
  • The Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition, is a valuable resource for understanding the size and growth potential of the molecular POC market from 2023-2028. mPOC has transitioned from a novel trend to a significant contributor to the market.
  • What's the size of the Molecular Point-of-Care Market: 2023-2028
    Geographic Breakout of the Molecular Point-of-Care Market, 2023 (N. America, Europe, APAC, RoW)
    Segment Breakout of Molecular Point-of-Care Market, 2023 (Respiratory vs. Other)
    Near Patient Molecular IVD Market: 2023-2028
    Near Patient Molecular Market Share by Vendor, 2023
    Companies covered in this report, in profiles and/or product tables and market developments discussion include:

Revvity's EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings

Retrieved on: 
Thursday, April 25, 2024
Partnership, PCR, European, Real-time, STI, Urinary tract infection, Patient, Immunodeficiency, IVDR

This collaboration brings together EUROIMMUN's extensive distribution network and support infrastructure with ALPCO-GeneProof's innovative molecular diagnostic technologies.

Key Points: 
  • This collaboration brings together EUROIMMUN's extensive distribution network and support infrastructure with ALPCO-GeneProof's innovative molecular diagnostic technologies.
  • "Entering into the partnership with ALPCO-GeneProof, EUROIMMUN is relying on an established and experienced provider for molecular diagnostic assays.
  • It will allow EUROIMMUN's customers to benefit from a vastly expanded high-quality assay portfolio that can be run on established real-time PCR cyclers," says Dirk Beecker, CEO of EUROIMMUN.
  • The agreement will see EUROIMMUN delivering a comprehensive portfolio of 42 molecular diagnostic assays from ALPCO-GeneProof.

Sensiva Health Partners With PointClickCare On The PCC Marketplace

Retrieved on: 
Thursday, April 25, 2024
FDA, Antibiotic, Electronic health record, PCC, EMR, Insurance, Partnership, ISO, Workflow, PCR, Health care, Science, Nursing, Doctor of Pharmacy, RT, Maple, UPS, COVID-19

ST. ROSE, La., April 25, 2024 /PRNewswire/ -- Today, Sensiva Health, which owns and operates a state-of-the-art molecular laboratory and ISO certified diagnostics manufacturing facility, announced their partnership with PointClickCare and has completed a full integration on the PCC marketplace. With this in place, PCC users across the country can now connect directly to their laboratory and view patient results in real-time, directly in the PointClickCare EHR.

Key Points: 
  • Sensiva Health has partnered with PointClickCare and has completed a full integration on the PCC Marketplace.
  • ST. ROSE, La., April 25, 2024 /PRNewswire/ -- Today, Sensiva Health, which owns and operates a state-of-the-art molecular laboratory and ISO certified diagnostics manufacturing facility, announced their partnership with PointClickCare and has completed a full integration on the PCC marketplace.
  • Sensiva Health has partnered with PointClickCare and has completed a full integration on the PCC Marketplace.
  • Of the company's most recent success, Ben Williamson, the Chief Operating Officer, Sensiva Health said, "We are thrilled to announce this partnership with PointClickCare and look forward to watching the PCC marketplace evolve moving forward.

Murphy's Naturals Ventures into a New Era with Updated Look and Feel

Retrieved on: 
Thursday, April 25, 2024
Target, Walmart, Whole Foods Market, Hope, Murphy, Marketing, REI, PCR, Schism, Mosquito, Silica gel, Trust, Paper, Natural, Private investigator

RALEIGH, N.C., April 25, 2024 /PRNewswire-PRWeb/ -- Murphy's Naturals (murphysnaturals.com), the outdoor lifestyle company helping others enjoy life outside since 2014, is proud to announce a major brand refresh as part of its mission to celebrate nature and inspire good through high-quality natural products.

Key Points: 
  • "At Murphy's Naturals, our mission is bigger than insect repellent; we aim to empower people to venture outdoors worry-free," said Murphy's Naturals Founder and CEO Philip Freeman.
  • The brand's updated look and feel includes a revamped logo and packaging designs inspired by Earth's palette, boasting shades of green and other colors that signify strength and trust.
  • "Our customers can expect the same great formulas, just with a visual makeover," said Mackenzie Donegan, Director of Marketing for Murphy's Naturals.
  • "At Murphy's Naturals, our mission is bigger than insect repellent; we aim to empower people to venture outdoors worry-free," said Murphy's Naturals Founder and CEO Philip Freeman.

Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan

Retrieved on: 
Wednesday, April 24, 2024
Sale, FDA, Learning, APRC, Tuberculosis, Business development, Conference, Infection, PCR, Respiratory disease, Notifiable disease, TB, COVID-19, Pharmaceutical industry

The theme for the 2024 conference is "Shaping a Safer World Through High-Quality Holistic Healthcare," reflecting the organizers' vision to discuss current evidence, share ideas and information, and accelerate innovation.

Key Points: 
  • The theme for the 2024 conference is "Shaping a Safer World Through High-Quality Holistic Healthcare," reflecting the organizers' vision to discuss current evidence, share ideas and information, and accelerate innovation.
  • Joseph Featherstone, the Company's Executive VP of Business Development, will be delivering a presentation on April 27th on accessible TB diagnostics on the Co-Dx PCR Pro™.
  • Attendees interested in learning more about Co-Dx and its products, including its upcoming Co-Dx PCR Pro instrument and tests, are invited to visit the Company at Booth B20.
  • The Co-Dx PCR Pro instrument and Co-Dx COVID-19 Test are currently under review by the FDA.

Alveo Technologies Partners with NYtor to Develop Rapid Molecular Test for the Dominant Swine Flu Strains

Retrieved on: 
Tuesday, April 23, 2024
Public, Agriculture, Animal, Partnership, LAMP, PCR, PRRS, Diagnosis, Pig

ALAMEDA, Calif., April 23, 2024 /PRNewswire/ -- Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary technology platform, today announced a partnership with NYtor B.V (The Netherlands), an innovative assay developer, to create a rapid, accurate, pen-side test that will detect the dominant swine flu strains, including H1N1, H1N2 and H3N2.

Key Points: 
  • If a group of infected pigs are brought into a new facility, the virus can spread rapidly through susceptible swine.
  • Even worse, newly infected swine could be moved to additional facilities, spreading swine flu throughout the new destination.
  • The Alveo platform, including its mobile app, Alveo Sense , is a rapid, handheld, reusable, and rugged multiplexed molecular diagnostic device.
  • NYtor is developing swine flu assays for the Alveo platform that will enable operations to monitor the flu status of their animals in real time with rapid, highly accurate pen-side tests.

Dionis Goat Milk Skincare Announces Refillable Lotion Program

Retrieved on: 
Monday, April 22, 2024
Honey, Cream, Skin, Carbon, PCR, Environment, Lotion, Vanilla, Recycling, Milk and Honey, Paraben, Cosmetics

BUCKS COUNTY, Pa., April 22, 2024 /PRNewswire/ -- Today, best-selling premium goat milk skincare brand Dionis Goat Milk Skincare is excited to announce the launch of their new Refillable Lotion Pouch. Committed to expanding their sustainability program, Dionis is transforming their product packaging to keep the environment at the forefront of development. The Refill/Reuse/Save initiative includes refillable body lotion bottles and body lotion pouches that use significantly fewer resources and reduce the overall carbon footprint when compared to rigid bottles.

Key Points: 
  • BUCKS COUNTY, Pa., April 22, 2024 /PRNewswire/ -- Today, best-selling premium goat milk skincare brand Dionis Goat Milk Skincare is excited to announce the launch of their new Refillable Lotion Pouch.
  • The Refill/Reuse/Save initiative includes refillable body lotion bottles and body lotion pouches that use significantly fewer resources and reduce the overall carbon footprint when compared to rigid bottles.
  • The top-selling, cult favorite goat milk body lotion is a high-quality, non-greasy formula that hydrates without the heavy feel.
  • Dionis Goat Milk Skincare's Refillable Lotion is retailing direct-to-consumer on www.dionisgmskincare.com .

Acer Commits to Collecting 50 Tons of Plastic Waste From the Environment Through Plastic Bank Partnership

Retrieved on: 
Monday, April 22, 2024
Acer, Plastic Bank, Biophysical environment, Computer, Partnership, Water, Vero, Life, Carbon, PCR, Environment, Plastic, ESG, Earth Day, Sustainable Development Goals, SDG, Acer Aspire, Maple syrup

TAIPEI, April 22, 2024 /PRNewswire/ -- Echoing this year's Earth Day theme of "Planet vs Plastics", Acer has partnered with Plastic Bank and has pledged to collect and recycle at least 50 tons of plastic waste from the environment in 2024. The Canada-based social enterprise focuses on tackling the growing issues of plastic pollution by building recycling ecosystems and creating livelihood opportunities in vulnerable coastal areas.

Key Points: 
  • The Canada-based social enterprise focuses on tackling the growing issues of plastic pollution by building recycling ecosystems and creating livelihood opportunities in vulnerable coastal areas.
  • Acer's Impact Program Partnership with Plastic Bank is projected to prevent the equivalent of more than 2.5 million plastic bottles[2] from entering the oceans through the efforts of collection members in Southeast Asia.
  • Members bring their collected plastic to Plastic Bank collection branches in exchange for the local market price of the gathered material as well as bonuses that help provide additional income and access to social benefits, like meal vouchers, health insurance, and more.
  • Acer will continue to evolve with the industry and changing lifestyles by promoting innovative and eco-conscious solutions for the long-term sustainability of its operations and the environment.